参考文献

［1］2019 Global Initiative for Chronic Obstructive Lung Disease: 2019 Global Strategy for Prevention, Diagnosis and Management of COPD Global Obstructive Lung Disease [R]. GOLD board, 2019.

［2］SPRUIT M A, SINGH S J, GARVEY C, et al. An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation[J/OL]. Am J Respir Crit Care Med, 2013, 188 （8）: e13-e64.

［3］CLINI E, HOLLAND A E, PITTA F, et al. Textbook of Pulmonary Rehabilitation [M]. Gewerbestrasse,Switzerland: Springer, 2018.

［4］HODGKIN J E, CELLI B R, CONNORS G A. Pulmonary rehabilitation: guidelines to success [M].4^th edition. St Louis, USA: Mosby, 2009.

［5］JONES P W. Interpreting thresholds for a clinically significant change in health status in asthma and COPD [J]. Eur Respir J, 2002, 19 （3）: 398-404.

［6］JAESCHKE R, SINGER J, GUYATT G H, et al. Measurement of health status. Ascertaining the minimal clinically important difference [J]. Control Clin Trials, 1989, 10 （4）: 407-415.

［7］KON SSC, CANAVAN J L, JONES S E, et al. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis [J/OL]. Lancet Respir Med, 2014, 2 （3）: 195-203.

［8］WYRWICH K W, TIERNEY W M, BABU A N, et al. A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease [J]. Health Serv Res, 2005, 40 （2）: 577-591.

［9］VITACCA M, PANERONI M, BAIARDI P, et al. Development of A-Barthel Index based on dyspnea for patients with respiratory diseases [J/OL]. Int J Chron Obstruct Pulmon Dis, 2016,11 （10）: 1199-1206.

［10］REGUEIRO E M, BURTIN C, BATEN P, et al. The minimal important difference of the pulmonary functional status and dyspnea questionnaire in patients with severe chronic obstructive pulmonary disease [J/OL]. Respir Res, 2013, 14 （1）: 58-58.

［11］SCHUNEMANN H J, GRIFFITH L, JAESCHKE R, et al. Evaluation of the minimal important difference for the feeling thermometer and the St. George’s Respiratory Questionnaire in patients with chronic airflow obstruction [J/OL]. J Clini Epidemiol, 2003, 56 （12）: 1170-1176.

［12］KUPFERBERG D H, KAPLAN R M, SLYMEN D J, et al. Minimal clinically important difference for the UCSD Shortness of Breath Questionnaire [J]. J Cardiopulm Rehabil, 2005, 25 （6）:370-377.

［13］DEN OUDSTEN B L, ZIJLSTRA W P, DE VRIES J, et al. The minimal clinical important difference in the World Health Organization Quality of Life instrument-100 [J/OL]. Support Care Cancer, 2013, 21 （5）: 1295-1301.

［14］LIANG W M, CHEN J J, CHANG C, et al. An empirical comparison of the WHOQOL-BREF and the SGRQ among patients with COPD [J/OL]. Qual Life Res, 2008, 17 （5）: 793-800.